SLC5A2 and diabetic kidney disease: First, we compared tubulointerstitial and glomerular log2 SLC5A2 mRNA expression levels and confirmed a predominant synthesis within the tubulointerstitial compartment in healthy controls and diabetic nephropathy (Figure 1A and Tables S1 and S2) [14].